{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:15:03Z","timestamp":1740143703939,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H27-\u533b\u85ac-\u6307\u5b9a-009"],"award-info":[{"award-number":["H27-\u533b\u85ac-\u6307\u5b9a-009"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11418-023-01687-w","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T05:25:47Z","timestamp":1677648347000},"page":"476-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of ephedrine and pseudoephedrine contents in 34 Kampo extracts containing Ephedrae Herba used clinically in Japan"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-9696","authenticated-orcid":false,"given":"Mitsuhiko","family":"Nose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoka","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Hisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Masada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hakamatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"unstructured":"The Ministry of Health, Labour and Welfare Ministerial Notification No. 64 (2016) Ephedra herb. In: The Japanese pharmacopoeia seventeenth edition. The Ministry of Health, Labour and Welfare, Japan, pp 1849","key":"1687_CR1"},{"key":"1687_CR2","first-page":"78","volume-title":"Introduction to Kampo; Japanese traditional medicine","author":"Y Sato","year":"2005","unstructured":"Sato Y (2005) Ephedra herb drug group. Introduction to Kampo; Japanese traditional medicine. Elsevier, Osaka, pp 78\u201381"},{"key":"1687_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s0166-3542(99)00067-4","volume":"44","author":"N Mantani","year":"1999","unstructured":"Mantani N, Andoh T, Kawamata H, Terasawa K, Ochiai H (1999) Inhibitory effect of Ephedrae Herba, an oriental traditional medicine, on the growth of influenza A\/PR\/8 virus in MDCK cells. Antiviral Res 44:193\u2013200. https:\/\/doi.org\/10.1016\/s0166-3542(99)00067-4","journal-title":"Antiviral Res"},{"key":"1687_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1254\/jphs.fp0060135","volume":"101","author":"K Minamizawa","year":"2006","unstructured":"Minamizawa K, Goto H, Shimada Y, Terasawa K, Haji A (2006) Effects of eppikahangeto, a Kampo formula, and Ephedrae Herba against citric acid-induced laryngeal cough in guinea pigs. J Pharmacol Sci 101:118\u2013125. https:\/\/doi.org\/10.1254\/jphs.fp0060135","journal-title":"J Pharmacol Sci"},{"key":"1687_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.phymed.2006.09.015","volume":"14","author":"T Kubo","year":"2007","unstructured":"Kubo T, Nishimura H (2007) Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children. Phytomedicine 14:96\u2013101. https:\/\/doi.org\/10.1016\/j.phymed.2006.09.015","journal-title":"Phytomedicine"},{"key":"1687_CR6","first-page":"700","volume":"32","author":"N Nagai","year":"1887","unstructured":"Nagai N (1887) Ephedrine. Pharm Ztg 32:700","journal-title":"Pharm Ztg"},{"key":"1687_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/s0006-2952(99)00152-5","volume":"58","author":"SS Vansal","year":"1999","unstructured":"Vansal SS, Feller DR (1999) Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol 58:807\u2013810. https:\/\/doi.org\/10.1016\/s0006-2952(99)00152-5","journal-title":"Biochem Pharmacol"},{"key":"1687_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1124\/jpet.107.120709","volume":"322","author":"G Ma","year":"2007","unstructured":"Ma G, Bavadekar SA, Davis YM, Lalchandani SG, Nagmani R, Khan SBT, Ikhlas ADR, Feller (2007) Pharmacological effects of ephedrine alkaloids on human a1- and a2-adrenergic receptor subtypes. J Pharmacol Exp Ther 322:214\u2013221. https:\/\/doi.org\/10.1124\/jpet.107.120709","journal-title":"J Pharmacol Exp Ther"},{"key":"1687_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0014-2999(71)90085-9","volume":"15","author":"LQ Pun","year":"1971","unstructured":"Pun LQ, Atkinson JM, Rand MJ (1971) Reversal of the bronchodilator action of ephedrine during ventilation with carbon dioxide. Eur J Pharmacol 15:110\u2013118. https:\/\/doi.org\/10.1016\/0014-2999(71)90085-9","journal-title":"Eur J Pharmacol"},{"key":"1687_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2125.1978.tb01681.x","volume":"6","author":"MG Britton","year":"1978","unstructured":"Britton MG, Empey DW, John GC, McDonnell KA, Hughes DT (1978) Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever. Br J Clin Pharmacol 6:51\u201358. https:\/\/doi.org\/10.1111\/j.1365-2125.1978.tb01681.x","journal-title":"Br J Clin Pharmacol"},{"key":"1687_CR11","first-page":"73","volume":"36","author":"SS Jawad","year":"1998","unstructured":"Jawad SS, Eccles R (1998) Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 36:73\u201376","journal-title":"Rhinology"},{"key":"1687_CR12","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1248\/cpb.28.2900","volume":"28","author":"H Hikino","year":"1980","unstructured":"Hikino H, Konno H, Takata H, Tamada M (1980) Antiinflammatory principle of Ephedra Herbs. Chem Pharm Bull 28:2900\u20132904. https:\/\/doi.org\/10.1248\/cpb.28.2900","journal-title":"Chem Pharm Bull"},{"key":"1687_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1006\/ebeh.2001.0281","volume":"2","author":"M Spinella","year":"2001","unstructured":"Spinella M (2001) Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy Behav 2:524\u2013532. https:\/\/doi.org\/10.1006\/ebeh.2001.0281","journal-title":"Epilepsy Behav"},{"key":"1687_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4065\/77.1.12","volume":"77","author":"D Samenuk","year":"2002","unstructured":"Samenuk D, Link MS, Homoud MK, Contreras R, Theohardes TC, Wang PJ, Estes NAM (2002) Adverse cardiovascular events temporally associated with Ma Huang, an herbal source of ephedrine. Mayo Clin Proc 77:12\u201316. https:\/\/doi.org\/10.4065\/77.1.12","journal-title":"Mayo Clin Proc"},{"key":"1687_CR15","first-page":"818","volume":"19","author":"E Ernst","year":"2003","unstructured":"Ernst E (2003) Cardiovascular adverse effects of herbal medicines: a systematic review of the recent literature. Can J Cardiol 19:818\u2013827","journal-title":"Can J Cardiol"},{"key":"1687_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11418-017-1101-x","volume":"71","author":"M Nose","year":"2017","unstructured":"Nose M, Tada M, Kojima R, Nagata K, Hisaka S, Masada S, Homma M, Hakamatsuka T (2017) Comparison of glycyrrhizin content in 25 major kinds of Kampo extracts containing Glycyrrhizae Radix used clinically in Japan. J Nat Med 71:711\u2013722. https:\/\/doi.org\/10.1007\/s11418-017-1101-x","journal-title":"J Nat Med"},{"key":"1687_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s11418-019-01325-4","volume":"73","author":"M Nose","year":"2019","unstructured":"Nose M, Tada M, Kato A, Hisaka S, Masada S, Homma M, Hakamatsuka T (2019) Effect of Schisandrae Fructus on glycyrrhizin content in Kampo extracts containing Glycyrrhizae Radix used clinically in Japan. J Nat Med 73:834\u2013840. https:\/\/doi.org\/10.1007\/s11418-019-01325-4","journal-title":"J Nat Med"},{"key":"1687_CR18","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1021\/jo00258a004","volume":"53","author":"M Fujita","year":"1988","unstructured":"Fujita M, Hiyama T (1988) Erythro-directive reduction of \u03b1-substituted alkanones by means of hydrosilanes in acidic media. J Org Chem 53:5415\u20135421. https:\/\/doi.org\/10.1021\/jo00258a004","journal-title":"J Org Chem"},{"key":"1687_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/s0731-7085(99)00065-5","volume":"20","author":"N Okamura","year":"1999","unstructured":"Okamura N, Miki H, Harada T, Yamashita S, Masaoka Y, Nakamoto Y, Tsuguma M, Yoshitomi H, Yagi A (1999) Simultaneous determination of ephedrine, pseudoephedrine, norephedrine and methylephedrine in Kampo medicines by high-performance liquid chromatography. J Pharm Biomed Anal 20:363\u2013372. https:\/\/doi.org\/10.1016\/s0731-7085(99)00065-5","journal-title":"J Pharm Biomed Anal"},{"key":"1687_CR20","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJM200012213432502","volume":"343","author":"CA Haller","year":"2000","unstructured":"Haller CA, Benowitz NL (2000) Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Eng J Med 343:1833\u20131838. https:\/\/doi.org\/10.1056\/NEJM200012213432502","journal-title":"N Eng J Med"},{"key":"1687_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.7326\/0003-4819-138-6-200303180-00010","volume":"138","author":"S Bent","year":"2003","unstructured":"Bent S, Tiedt TN, Odden MC, Shipak MG (2003) The relative safety of Ephedra compared with other herbal products. Ann Intern Med 138:468\u2013471. https:\/\/doi.org\/10.7326\/0003-4819-138-6-200303180-00010","journal-title":"Ann Intern Med"},{"key":"1687_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/01926230701459978","volume":"35","author":"JK Dunnick","year":"2007","unstructured":"Dunnick JK, Kissling G, Gerken DK, Vallant MA, Nyska A (2007) Cardiotoxicity of Ma Huang\/caffeine or ephedrine\/caffeine in a rodent model system. Toxicol Pathol 35:657\u2013664. https:\/\/doi.org\/10.1080\/01926230701459978","journal-title":"Toxicol Pathol"},{"key":"1687_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/ajhp\/57.10.963","volume":"57","author":"BJ Gurley","year":"2000","unstructured":"Gurley BJ, Gardner SF, Hubbard MA (2000) Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 57:963\u2013969. https:\/\/doi.org\/10.1093\/ajhp\/57.10.963","journal-title":"Am J Health Syst Pharm"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-023-01687-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-023-01687-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-023-01687-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T04:30:57Z","timestamp":1685334657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-023-01687-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1007\/s11418-023-01687-w","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"type":"print","value":"1340-3443"},{"type":"electronic","value":"1861-0293"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"25 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}